Stock Rating Upgrade The Value Trend Rating for Ligand Pharmaceuticals Inc (NASDAQ: LGND) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
Stock Rating Upgrade In recent days the Value Trend Rating for Kirby Corp (NYSE: KEX) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 3/8/24, Kirby Corp (NYSE: […]
Inseego Corp (NASDAQ: INSG) stock enjoyed a major increase of 15.8% on 3/8/24. The shares closed at $3.51. Moreover, unusually high trading volume at 178% of normal accompanied the advance. The stock has been extremely […]
Inovio Pharmaceuticals Inc (NASDAQ: INO) stock closed at $10.18 on 3/8/24 after a major increase of 12.7%. Moreover, unusually high trading volume at 193% of normal accompanied the advance. The stock has risen 14.9% during […]
Genesco Inc. (NYSE: GCO) has reported E.P.S. of $1.86 for its fourth fiscal quarter (ending January 31) versus $3.29 for the same period a year ago — a decline of -43%. This result fell short […]
Recent important positive changes in fundamentals have benefitted EMCOR Group Inc. (NYSE: EME): the consensus estimate for December, 2025 increased significantly, the consensus estimate for December, 2024 increased significantly, and significant quarterly earnings acceleration occurred. […]
Stock Rating Upgrade The Value Trend Rating for DXC Technology Co (NYSE: DXC) improved recently from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our […]
Extremely significant negative changes in Cross Country Healthcare Inc (NASDAQ: CCRN) fundamentals have recently occurred: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2025 decreased significantly, and the […]
Credit Acceptance Corp (NASDAQ: CACC) has benefited from extremely meaningful positive changes in fundamentals: the consensus estimate for December, 2024 increased significantly, the stock’s power rating rose above 70, the consensus estimate for December, 2025 […]
Stock Rating Upgrade The Value Trend Rating for Codexis Inc (NASDAQ: CDXS) improved during the last several trading days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research